Target intelligence / Profile preview

MicroRNA 101-1 (miR-101-1)

Target
miR-101-1
Molecular classification
MicroRNA, Non-coding RNA, Gene regulator, Other
01

Overview

MicroRNA 101-1 (miR-101-1) is a small, non-coding RNA molecule classified as a microRNA, encoded by the MIR101-1 gene on chromosome 1p31.3. It acts chiefly as a tumor suppressor in multiple cancer types by post-transcriptionally repressing several oncogenes (notably EZH2, MCL-1, and FOS), and thereby suppresses tumor cell proliferation, migration, invasion, stemness, and drug resistance[1][2][3]. It is highly conserved, regulates gene expression mainly via binding to the 3’ untranslated region (3’UTR) of target mRNAs, and participates in processes such as apoptosis, angiogenesis, and modulation of the tumor microenvironment[1][2]. Its downregulation is associated with poor prognosis in various cancers; conversely, there is some evidence for context-dependent oncogenic roles in select malignancies[2][3].

Other names
hsa-mir-101-1MIRN101-1mir-101-1MIR101-1
02

Mechanism of action

Post-transcriptional repression of oncogenes such as EZH2, MCL-1, and FOS[2][1]

03

Biological functions

Regulation of gene expressionCell proliferationApoptosisCell migrationCell invasionEpithelial-mesenchymal transition (EMT)Drug resistanceAngiogenesis
04

Disease associations

CancerFibrosisCardiovascular diseaseCerebrovascular diseaseOther
05

Safety considerations

Context-dependent effects—may act as either tumor suppressor or oncogene depending on tissue and disease context[2][3]potential for off-target gene regulation and unknown effects in normal tissues[3]
06

Interacting drugs

paclitaxel (sensitization of cancer cells)[2]
07

Biomarkers

Downregulation as a biomarker for cancer progression and prognosis[1][3]

Beyond the preview

Go deeper on MicroRNA 101-1 (miR-101-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 101-1 (miR-101-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call